A Study of Screening for Quality of Life, Depression, and Psoriatic Arthritis in Patients with Psoriasis


About this study

The purpose of this study is to promote patient-centered care by efficiently determining the presence of quality of life issues and their relation to depression and psoriatic arthritis in psoriasis patients. Screening for quality of life, depression, and psoriatic arthritis is a standard of care for psoriasis patients.   

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients 18 years or older
  • Diagnosis of psoriasis
  • Non-pregnant
  • English speakers

Exclusion Criteria:

  • Patients under the age of 18
  • No diagnosis of psoriasis
  • Pregnant
  • Non-English speakers

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Catherine Walker, M.S.N., R.N.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer